Botulinum toxins types A and B for brow furrows: Preliminary experiences with type B toxin dosing

Journal of Cosmetic and Laser Therapy

Volumn 4, Issue 1, 2002, Pages 15-18

  Lowe, Nicholas J ^a,b   Yamauchi, Paul S ^a,b   Lask, Gary P ^a,b   Patnaik, Rickie ^b   Moore, Donna ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

Botulinum toxins A B; Brow furrows

Indexed keywords

BOTULINUM TOXIN A; BOTULINUM TOXIN B;

ADULT; AGED; ARTICLE; BROW FURROW; CAPILLARY RESISTANCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG EFFICACY; DRY EYE; FEMALE; HEADACHE; HUMAN; INJECTION PAIN; PRIORITY JOURNAL; PTOSIS; SIDE EFFECT; SKIN DEFECT; TREATMENT OUTCOME; XEROSTOMIA;

ADULT; AGED; BOTULINUM TOXIN TYPE A; BOTULINUM TOXINS; FEMALE; HUMANS; METALLOENDOPEPTIDASES; MIDDLE AGED; NEUROMUSCULAR AGENTS; SKIN AGING; TREATMENT OUTCOME;

EID: 0036521580     PISSN: 14764172     EISSN: None     Source Type: Journal    
DOI: 10.1080/14764170260030117     Document Type: Article

References (13)

1. Simpson LL. The action of botulinal toxin. Rev Infect Dis 1979; 1: 656-62.
2. Hallett M. One man's poison - clinical applications of botulinum toxin. N Engl J Med 1999; 341: 118-20.
3. Blitzer A, Binder WJ, Aviv JE, Keen MS, Brin MF. The management of hyperfunctional facial lines with botulinum toxin. A collaborative study of 210 injection sites in 162 patients. Arch Otolaryngol Head Neck Surg 1997; 123: 389-92.
4. Carruthers A, Carruthers J. Cosmetic uses of botulinum A exotoxin. Adv Dermatol 1997; 12: 325-47; discussion 348.
5. Carruthers A, Kiene K, Carruthers J. Botulinum A exotoxin use in clinical dermatology. J Am Acad Dermatol 1996; 34: 788-97.
6. Klein AW. Cosmetic therapy with botulinum toxin, Anecdotal memoirs. Dermatol Surg 1996; 22: 757-9.
7. Lowe NJ, Maxwell A, Harper H. Botulinum A exotoxin for glabellar folds: a double-blind, placebo-controlled study with an electromyographic injection technique. J Am Acad Dermatol 1996; 35: 569-72.
8. Lew MF, Brashear A, Factor S. The safety and efficacy of botulinum toxin type B in the treatment of patients with cervical dystonia: summary of three controlled clinical trials. Neurology 2000; 55 (suppl): S29-35.
9. Brashear A, Lew MF, Dykstra DD et al. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia. Neurology 1999; 53: 1439-46.
10. Brin MF, Lew MF, Adler CH et al. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia. Neurology 1999; 53: 1431-8.
11. Carruthers A, Lowe NJ, Menter A. Botulinum toxin A for glabellar lines. J Am Acad Dermatol (in press).
12. Klein AW, Glogau RG. Botulinum toxin: beyond cosmesis. Arch Dermatol 2000; 136: 539-41.
13. Sloop RR, Cole BA, Escutin RO. Human response to botulinum toxin injection: type B compared with type A. Neurology 1997; 49: 189-94.